Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: $$$.19 with a bullet

"IBIS will not try to sell and no new equity fund investors will purchase stock unless at least 1 or 2 patents are re-certified or super strong personal assurances that they will be.

That is the bottom line."

The statement above is I believe is absurd.... you are saying we have hired them & will not even try!!!

Last year we had 6 funds invested in PTSC now 4... no patenets where validates...yet they bought...PTSC has done more since then for what they control...... your above statement seems to me to be bashing.......

Share
New Message
Please login to post a reply